264 related articles for article (PubMed ID: 25918249)
1. Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation.
Wang N; Wang Z; Wang Y; Xie X; Shen J; Peng C; You J; Peng F; Tang H; Guan X; Chen J
Oncotarget; 2015; 6(12):9854-76. PubMed ID: 25918249
[TBL] [Abstract][Full Text] [Related]
2. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling.
Wang N; Wang Z; Peng C; You J; Shen J; Han S; Chen J
Carcinogenesis; 2014 Nov; 35(11):2544-54. PubMed ID: 25194164
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1.
Liu J; Lam JB; Chow KH; Xu A; Lam KS; Moon RT; Wang Y
Carcinogenesis; 2008 Nov; 29(11):2195-202. PubMed ID: 18701434
[TBL] [Abstract][Full Text] [Related]
4. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
5. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.
Wang Z; Wang N; Han S; Wang D; Mo S; Yu L; Huang H; Tsui K; Shen J; Chen J
PLoS One; 2013; 8(7):e68566. PubMed ID: 23861918
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
7. DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis.
Pathania R; Ramachandran S; Elangovan S; Padia R; Yang P; Cinghu S; Veeranan-Karmegam R; Arjunan P; Gnana-Prakasam JP; Sadanand F; Pei L; Chang CS; Choi JH; Shi H; Manicassamy S; Prasad PD; Sharma S; Ganapathy V; Jothi R; Thangaraju M
Nat Commun; 2015 Apr; 6():6910. PubMed ID: 25908435
[TBL] [Abstract][Full Text] [Related]
8. Triptolide exhibits antitumor effects by reversing hypermethylation of WIF‑1 in lung cancer cells.
Mao X; Tong J; Wang Y; Zhu Z; Yin Y; Wang Y
Mol Med Rep; 2018 Sep; 18(3):3041-3049. PubMed ID: 30015908
[TBL] [Abstract][Full Text] [Related]
9. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
[TBL] [Abstract][Full Text] [Related]
10. Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer.
Mu J; Hui T; Shao B; Li L; Du Z; Lu L; Ye L; Li S; Li Q; Xiao Q; Qiu Z; Zhang Y; Fan J; Ren G; Tao Q; Xiang T
Oncotarget; 2017 Jun; 8(24):39443-39459. PubMed ID: 28467796
[TBL] [Abstract][Full Text] [Related]
11. c‑Jun suppresses the expression of WNT inhibitory factor 1 through transcriptional regulation and interaction with DNA methyltransferase 1 in gallbladder cancer.
Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
Mol Med Rep; 2018 Jun; 17(6):8180-8188. PubMed ID: 29693707
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells.
Wang KL; Hsia SM; Chan CJ; Chang FY; Huang CY; Bau DT; Wang PS
Expert Opin Ther Targets; 2013 Apr; 17(4):337-49. PubMed ID: 23327692
[TBL] [Abstract][Full Text] [Related]
13. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
[TBL] [Abstract][Full Text] [Related]
14. Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells.
Wang N; Wang Q; Tang H; Zhang F; Zheng Y; Wang S; Zhang J; Wang Z; Xie X
J Exp Clin Cancer Res; 2017 Dec; 36(1):172. PubMed ID: 29197410
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
[TBL] [Abstract][Full Text] [Related]
16. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
17. Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit.
Mak KK; Wu AT; Lee WH; Chang TC; Chiou JF; Wang LS; Wu CH; Huang CY; Shieh YS; Chao TY; Ho CT; Yen GC; Yeh CT
Mol Nutr Food Res; 2013 Jul; 57(7):1123-34. PubMed ID: 23504987
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic and metabolic regulation of breast cancer stem cells.
Liu HX; Li XL; Dong CF
J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
[TBL] [Abstract][Full Text] [Related]
19. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression.
Chen Z; Zhang Y; Jia C; Wang Y; Lai P; Zhou X; Wang Y; Song Q; Lin J; Ren Z; Gao Q; Zhao Z; Zheng H; Wan Z; Gao T; Zhao A; Dai Y; Bai X
Oncogene; 2014 Sep; 33(37):4548-57. PubMed ID: 24096482
[TBL] [Abstract][Full Text] [Related]
20. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
